Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference
ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that the Company will be presenting at the 2022 BIO CEO &…
Comments Off on Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference